|
b-Nicotinamide adenine dinucleotide phosphate disodium salt
|
|
24292-60-2
|
|
Benzyl 3,5-bis(phenylmethoxy)benzoate
|
|
50513-72-9
|
|
Olaparib
|
|
763113-22-0
|
|
DBeQ
|
|
177355-84-9
|
|
Labetalol Impurity A
|
|
1391051-99-2
|
|
6-Desacetyl-6-Bromo Palbociclib
|
|
851067-56-6
|
|
Safinamide Impurity 5
|
|
1160513-60-9
|
|
4-Hydroxy Omeprazole Sodium Salt
|
|
1803449-15-1
|
|
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethanone
|
|
52144-92-0
|
|
5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine
|
|
1823404-28-9
|
|
5-Fluoro-2'-deoxyuridine-5'-triphosphate (triethylammonium salt form)
|
|
1621676-99-0
|
|
Quetiapine Impurity F (11-Chlorodibenzo[b,f][1,4]thiazepine)
|
|
13745-86-3
|
|
Parimifasor
|
|
1796641-10-5
|
|
Clopidogrel Related Compound B
|
|
144750-52-7
|
|
N-Methyl-2-(4-methyl-1-piperazinyl)-N-(4-nitrophenyl)acetamide
|
|
1139453-98-7
|
|
Sparsentan (RE-021)
|
|
254740-64-2
|
|
RGW 611
|
|
6497-78-5
|
|
E260
|
|
1241537-79-0
|
|
(±)-Anatabine
|
|
2743-90-0
|
|
NADH (disodium salt)
|
|
606-68-8
|
|
1,4-Bis(4-nitrophenyl)piperazine
|
|
16264-05-4
|
|
GSK-2018682
|
|
1034688-30-6
|
|
(2R)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
|
|
174756-44-6
|
|
Sitagliptin phenylcrotonyl analog
|
|
1253056-18-6
|
|
Tenofovir Related Compound 1
|
|
342631-41-8
|
|
Rivaroxaban EP Impurity J
|
|
1632463-24-1
|
|
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethanone sulfate (2:1)
|
|
52144-93-1
|
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide hydrochloride
|
|
2037385-84-3
|
|
Enalapril EP Impurity D
|
|
115729-52-7
|
|
(R,S)-Palonosetron HCl
|
|
135755-51-0
|
|
Pidotimod Impurity X
|
|
161771-75-1
|
|
Ketoconazole EP Impurity C
|
|
83374-59-8
|
|
Nimesulide Impurity F
|
|
51765-72-1
|
|
6-Desacetyl Palbociclib Hydrochloride
|
|
571189-66-7
|
|
BAR-501
|
|
1632118-69-4
|
|
Humulone
|
|
26472-41-3
|
|
N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine Dihydrochloride
|
|
111974-74-4
|
|
Ethyl 3,5-bis(benzyloxy)benzoate
|
|
50841-46-8
|
|
Rivastigmine USP Related Compound F
|
|
1346602-84-3
|
|
Sofosbuvir Impurity (GS-566500)
|
|
1233335-78-8
|
|
Paclitaxel EP Impurity H
|
|
78454-17-8
|
|
Sitagliptin styrylacetyl analog
|
|
1803026-58-5
|
|
Bisoprolol EP Impurity L hydrochloride
|
|
1956321-87-1
|
|
Naratriptan Hydrochloride
|
|
143388-64-1
|
|
Ketotifen Impurity B
|
|
59743-88-3
|
|
Dicresulene
|
|
78480-14-5
|
|
FMK
|
|
821794-92-7
|
|
Tenofovir Disoproxil USP Related Compound H
|
|
1244022-54-5
|
|
Tetracaine Impurity C
|
|
71839-12-8
|
|
Pidotimod Impurity Y
|
|
161771-76-2
|
|
4-Desmethoxy Omeprazole Sulfide
|
|
704910-89-4
|
|
RBC8
|
|
361185-42-4
|
|
GSK2982772
|
|
1622848-92-3
|
|
Sitagliptin Fumarate Adduct (Mixture of Diastereomers)
|
|
2088771-60-0
|
|
6-Bromo-8-cyclopentyl-2-[[5-(4-Boc-1-piperazinyl)-2-pyridyl]amino]-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
|
|
571188-82-4
|
|
Rac-cis-Sertraline Hydrochloride
|
|
79617-95-1
|
|
1-Methylpyridin-1-ium-2-carboxamide
|
|
45750-74-1
|
|
4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenaminehydrochloride
|
|
79617-89-3
|
|
Nimesulide Impurity E
|
|
905858-63-1
|
|
4-(2,4-Diaminophenyl)morpholin-3-one
|
|
482308-13-4
|
|
(3R,5S)-5-Biphenyl-4-ylmethyl-3-methylpyrrolidin-2-one
|
|
1038924-70-7
|
|
Rivaroxaban EP Impurity I
|
|
1151893-81-0
|
|
β-Nicotinamide Mononucleotide
|
|
1094-61-7
|
|
2,5-Dioxopyrrolidine Sacubitril
|
|
1038924-97-8
|
|
(3alpha,5beta,6beta,7alpha)-6-Ethylcholane-3,7,24-triol
|
|
1632118-70-7
|
|
Pabociclib Impurity B Hydrochloride
|
|
1883672-48-7
|
|
SPHINX31
|
|
1818389-84-2
|
|
GGTI-298
|
|
180977-44-0
|
|
Clopidogrel EP Impurity A
|
|
144457-28-3
|
|
Levothyroxine EP Impurity J
|
|
4604-41-5
|
|
Detrothyronine
|
|
5714-08-9
|
|
Tariquidar
|
|
206873-63-4
|
|
N-Formyl-L-kynurenine
|
|
3978-11-8
|
|
N-Acetyl Sitagliptin
|
|
1379666-94-0
|
|
Pemetrexed Impurity E Disodium Salt
|
|
937370-10-0
|
|
3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
|
|
641571-16-6
|
|
7-Troc-paclitaxel
|
|
114915-17-2
|
|
((R)-2-Biphenyl-4-yl-1-formylethyl)carbamic Acid t-Butyl Ester
|
|
149709-58-0
|
|
SHP099 HCl
|
|
1801747-11-4
|
|
1-(3,5-bis(benzyloxy)phenyl)-2-(tert-butylamino)ethanone
|
|
52144-90-8
|
|
Lepirudin
|
|
138068-37-8
|
|
Omeprazole
|
|
73590-58-6
|
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide
|
|
1038972-16-5
|
|
Palonosetron N-Oxide
|
|
813425-83-1
|
|
Paliperidone Palmitate
|
|
199739-10-1
|
|
Methyl 1-Acetyl-2-oxoindoline-6-carboxylate
|
|
676326-36-6
|
|
Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
|
|
866084-31-3
|
|
Omeprazole Related Compound 10
|
|
142885-92-5
|
|
N-2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethylsilodosin
|
|
1453221-45-8
|
|
Protein Kinase Inhibitors 1
|
|
1365986-44-2
|
|
MTIC
|
|
3413-72-7
|
|
2-Bromo-3',5'-dibenzyloxyacetphenone
|
|
28924-18-7
|
|
(R)-Omeprazole Sodium Salt
|
|
161796-77-6
|
|
Tenapanor
|
|
1234423-95-0
|
|
WEHI-345
|
|
1354825-58-3
|
|
Safinamide Impurity 8
|
|
690969-16-5
|
|
tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
|
|
571189-65-6
|
|
(S)-2-(2-((4-(5-((5-Chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid hydrochloride
|
|
931117-61-2
|
|
Salirasib
|
|
162520-00-5
|
|
N-[[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]hydroxyphosphinyl]-D-alanine
|
|
376633-24-8
|